Submission Details
| 510(k) Number | K024339 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 27, 2002 |
| Decision Date | April 07, 2003 |
| Days to Decision | 101 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Statement |
K024339 is an FDA 510(k) clearance for the COZART EIA OPIATES ORAL FLUID KIT, a Cholinesterase Test Paper (Class I — General Controls, product code DIG), submitted by Cozart Bioscience , Ltd. (Oxfordshire Ox14 4ru, GB). The FDA issued a Cleared decision on April 7, 2003, 101 days after receiving the submission on December 27, 2002. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3240.
| 510(k) Number | K024339 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 27, 2002 |
| Decision Date | April 07, 2003 |
| Days to Decision | 101 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Statement |
| Product Code | DIG — Cholinesterase Test Paper |
| Device Class | Class I — General Controls |
| CFR Regulation | 21 CFR 862.3240 |